Proven effective in treating skin and upper respiratory infections
LINCOCIN (lincomycin hydrochloride) is indicated in the treatment of infections caused by Gram-positive organisms that are sensitive to its action, particularly streptococci and staphylococci.
LINCOCIN is indicated for the treatment of skin infections (pustular dermatitis, abscesses, infected wounds [including bite and fight wounds]), upper respiratory tract infections (tonsillitis, laryngitis), metritis, and secondary bacterial infections associated with the canine distemper-hepatitis complex.
LINCOCIN is indicated for the treatment of localized infections, such as abscesses, pneumonitis, and feline rhinotracheitis.
Each mL containing lincomycin hydrochloride equivalent to lincomycin, 50 mg; preserved with methylparaben 0.075%, propylparaben 0.025%, and sorbic acid 0.1%. Supplied in 20 mL bottles with graduated dropper.